Number of Shares
15,686.00
Current Holdings Value*
£2.25 Mil
% of Portfolio
1.64%
Total Estimate Gain
£118,116.79
% of Total Estimate Gain
6.07%

T. Rowe Price Global Value Equity Fund's AstraZeneca PLC Holding Summary

As of 2025-04-30, T. Rowe Price Global Value Equity Fund held 15,686.00 shares of AstraZeneca PLC(LSE:AZN), totaling £2.25 Mil. This investment constitutes 1.64% of their stock portfolio, and T. Rowe Price Global Value Equity Fund now holds 0% of the outstanding AstraZeneca PLC(LSE:AZN) stock.

The initial trade took place in 2021Q4. And since then T. Rowe Price Global Value Equity Fund has made 7 purchases of LSE:AZN, at an average price of £101.64, for a total of 19,160.00 shares. In addition, there have been 6 sales at an average price of £113.14 for 3,474.00 shares. Based on historical transaction data and LSE:AZN's current price of £106.62, T. Rowe Price Global Value Equity Fund's estimated gain on his LSE:AZN holdings is £118,116.79, reflecting a 6.07% gain to date.

T. Rowe Price Global Value Equity Fund LSE:AZN (£106.62) Holding Chart

T. Rowe Price Global Value Equity Fund LSE:AZN (£106.62) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price £-/Share
Shares Sold 0 Average Price £-/Share
Current Price £0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1